Literature DB >> 30390771

Ovarian Cancer.

Ursula A Matulonis1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30390771     DOI： 10.1016/j.hoc.2018.09.006

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


× No keyword cloud information.
  8 in total

Review 1.  Immunotherapy in the Treatment of Platinum-Resistant Ovarian Cancer: Current Perspectives.

Authors:  Ahmad Awada; Sarfraz Ahmad; Nathalie D McKenzie; Robert W Holloway
Journal:  Onco Targets Ther       Date:  2022-08-10       Impact factor: 4.345

2.  RHPN2 Promotes Malignant Cell Behaviours in Ovarian Cancer by Activating STAT3 Signalling.

Authors:  Fengsheng Yu; Pingping Qiao; Guangjie Yin; Yewu Sun; Xiao Yu; Xin Sun; Yijing Chu; Yankui Wang
Journal:  Onco Targets Ther       Date:  2020-11-10       Impact factor: 4.147

3.  Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy.

Authors:  Liang Lin; Li Chen; Zuolian Xie; Jian Chen; Ling Li; An Lin
Journal:  Front Genet       Date:  2022-06-16       Impact factor: 4.772

Review 4.  Role of Pyroptosis in Gynecological Oncology and Its Therapeutic Regulation.

Authors:  Yi Huang; Ruiyun Li; Yuan Yang
Journal:  Biomolecules       Date:  2022-07-01

Review 5.  Emerging role of circRNAs in cancer under hypoxia.

Authors:  Qun Lai; Wenqiang Li; Hongping Wang; Siran Xu; Zhiping Deng
Journal:  Oncol Lett       Date:  2022-09-05       Impact factor: 3.111

6.  NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer.

Authors:  Claudia Marchetti; Marco D'Indinosante; Carolina Bottoni; Chiara Di Ilio; Stefano Di Berardino; Barbara Costantini; Angelo Minucci; Laura Vertechy; Giovanni Scambia; Anna Fagotti
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

7.  A novel ferroptosis related gene signature is associated with prognosis in patients with ovarian serous cystadenocarcinoma.

Authors:  Zhixiang Yu; Haiyan He; Yanan Chen; Qiuhe Ji; Min Sun
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

8.  OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence.

Authors:  Francesca Megiorni; Simona Camero; Paola Pontecorvi; Lucrezia Camicia; Francesco Marampon; Simona Ceccarelli; Eleni Anastasiadou; Nicola Bernabò; Giorgia Perniola; Antonio Pizzuti; Pierluigi Benedetti Panici; Vincenzo Tombolini; Cinzia Marchese
Journal:  Cancers (Basel)       Date:  2021-03-25       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.